expect good news with agm near, page-5

My chart looks good (heading for)for an up-swing. The company's own valuation of SP after the issue was 85c so there is definitly room for an increase in SP. There is still uncertainty about the future of pharmacuetical retailing due to government intention on reforms but API has repositioned itself to the wholesaling side. (and have you seen the price of vitamins!) When it comes to health people seem to have a lot of tolerance on price.

The above comments are not to be construed as financial advice. DYOR.